Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA november 4, 20220OpmerkingenEN NL Read More
Oxurion Receives Transparency Notification from Fidelity Management & Research Company LLC november 4, 20220OpmerkingenEN NL Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA oktober 28, 20220OpmerkingenEN NL Read More
American Academy of Ophthalmology (AAO) 2022 Annual Meeting – Chicago, IL september 30, 20220Opmerkingen Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA september 30, 20220OpmerkingenEN NL Read More
Oxurion To Participate in Upcoming Scientific and Investor Conferences september 12, 20220OpmerkingenEN Read More
Speciaal verslag van de Raad van Bestuur – 2 september 2022 september 2, 20220OpmerkingenSpeciaal verslag van de Raad van Bestuur Read More
Beoordelingsverslag van de commissaris aan de Raad van Bestuur – 2 september 2022 september 2, 20220OpmerkingenAuditor's Report to the Board of Directors (NL only) Read More
Board of Directors Special Report – September 2, 2022 september 2, 20220OpmerkingenSpecial report of the Board of Directors Read More
Beoordelingsverslag van de commissaris aan de Raad van Bestuur – 2 september 2022 september 2, 20220OpmerkingenAuditor's Report to the Board of Directors (NL only) Read More
Oxurion Announces Amendment to Funding Program with Negma Group for EUR 6 Million in Funding september 2, 20220OpmerkingenEN NL Read More
Prospectus Nieuwe Aandelen – 30 augustus 2022 augustus 30, 20220OpmerkingenProspectus voor de toelating tot de handel op Euronext Brussels van maximal 30.500.000 nieuwe aandelen Read More
Supplement op het Prospectus d.d. 30 augustus 2022 augustus 30, 20220OpmerkingenSupplement op het Prospectus d.d. 30 augustus 2022 Read More
New Shares Prospectus – August 30, 2022 augustus 30, 20220OpmerkingenProspectus for the admission to trading on Euronext Brussels of up to 30,500,000 new shares Read More
Supplement to the Prospectus of 30 August 2022 augustus 30, 20220OpmerkingenSupplement to the Prospectus of 30 August 2022 Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA augustus 26, 20220OpmerkingenEN NL Read More
Oxurion To Present at Upcoming Scientific and Investor Conferences augustus 24, 20220OpmerkingenEN Read More
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA juli 29, 20220OpmerkingenEN NL Read More
